Safety and immunogenicity of ChAdOx1 nCoV-19 (AZD1222) vaccine in adults in Kenya: a phase 1/2 single-blind, randomised controlled trial by Hamaluba, M, Sang, S, Orindi, B, Njau, I, Karanja, H, Kamau, N, Gitonga, J, Mugo, D, Wright, D, Nyagwange, J, Kutima, B, Omuoyo, D, Mwatasa, M, Ngetsa, C, Agoti, C, Cheruiyot, S, Nyaguara, A, Munene, M, Mturi, N, Oloo, E, Ochola-Oyier, L, Mumba, N, Mauncho, C, Namayi, R, Davies, A, Tsofa, B, Nduati, E, Aliyan, N, Kasera, K, Etyang, A, Boyd, A, Hill, A, Gilbert, S, Douglas, A, Pollard, A, Bejon, P, Lambe, T, Warimwe, G